These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9774604)

  • 1. Comparison of the QUANTIPLEX HIV-1 RNA 2.0 assay with the AMPLICOR HIV-1 MONITOR 1.0 assay for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving stavudine-didanosine combination therapy.
    Segondy M; Izopet J; Pellegrin I; Montes B; Dumon B; Pasquier C; Peeters M; Fleury HJ; Puel J; Reynes J
    J Clin Microbiol; 1998 Nov; 36(11):3392-5. PubMed ID: 9774604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Quantiplex version 3.0 assay and a sensitized Amplicor monitor assay for measurement of human immunodeficiency virus type 1 RNA levels in plasma samples.
    Highbarger HC; Alvord WG; Jiang MK; Shah AS; Metcalf JA; Lane HC; Dewar RL
    J Clin Microbiol; 1999 Nov; 37(11):3612-4. PubMed ID: 10523562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplicor HIV monitor, NASBA HIV-1 RNA QT and quantiplex HIV RNA version 2.0 viral load assays: a Canadian evaluation.
    Prud'homme IT; Kim JE; Pilon RG; Minkus T; Hawley-Foss N; Cameron W; Rud EW
    J Clin Virol; 1998 Dec; 11(3):189-202. PubMed ID: 9949955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in cell-free cervicovaginal secretions: comparison of reverse transcription-PCR amplification (AMPLICOR HIV-A MONITOR 1.5) with enhanced-sensitivity branched-DNA assay (Quantiplex 3.0).
    Si-Mohamed A; Andreoletti L; Colombet I; Carreno MP; Lopez G; Chatelier G; Kazatchkine MD; Belec L
    J Clin Microbiol; 2001 Jun; 39(6):2055-9. PubMed ID: 11376034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Amplicor HIV-1 monitor test and the nucleic acid sequence-based amplification assay for quantitation of human immunodeficiency virus RNA in plasma, serum, and plasma subjected to freeze-thaw cycles.
    Griffith BP; Rigsby MO; Garner RB; Gordon MM; Chacko TM
    J Clin Microbiol; 1997 Dec; 35(12):3288-91. PubMed ID: 9399536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Coste J; Montes B; Reynes J; Peeters M; Segarra C; Vendrell JP; Delaporte E; Segondy M
    J Med Virol; 1996 Dec; 50(4):293-302. PubMed ID: 8950685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma.
    Revets H; Marissens D; de Wit S; Lacor P; Clumeck N; Lauwers S; Zissis G
    J Clin Microbiol; 1996 May; 34(5):1058-64. PubMed ID: 8727875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant differences between plasma HIV-1 RNA assays in HIV-1 subtype E infected patients treated with antiretroviral therapy.
    Ruxrungtham K; Ubolyam S; Hassink EA; Ungsedhapand C; Kroon E; Duncombe C; Weverling GJ; Nookai S; Lange J; Cooper D; Phanuphak P
    Asian Pac J Allergy Immunol; 2002 Jun; 20(2):105-11. PubMed ID: 12403195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5.
    Elbeik T; Charlebois E; Nassos P; Kahn J; Hecht FM; Yajko D; Ng V; Hadley K
    J Clin Microbiol; 2000 Mar; 38(3):1113-20. PubMed ID: 10699005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance characteristics of the QUANTIPLEX HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Erice A; Brambilla D; Bremer J; Jackson JB; Kokka R; Yen-Lieberman B; Coombs RW
    J Clin Microbiol; 2000 Aug; 38(8):2837-45. PubMed ID: 10921936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of three different commercial procedures for quantifying human immunodeficiency virus type-1 RNA levels.
    Aschbacher R; Monari P; Lolli S; Donzelli C; Colangeli V; Vignoli M; Ramazzotti E; Furlini G; Re MC
    New Microbiol; 1999 Jan; 22(1):1-9. PubMed ID: 10190111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
    García F; Romeu J; Grau I; Sambeat MA; Dalmau D; Knobel H; Gomez-Sirvent JL; Arrizabalaga J; Cruceta A; Clotet BG; Podzamczer D; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
    AIDS; 1999 Dec; 13(17):2377-88. PubMed ID: 10597779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma.
    Murphy DG; Côté L; Fauvel M; René P; Vincelette J
    J Clin Microbiol; 2000 Nov; 38(11):4034-41. PubMed ID: 11060065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of stavudine plus didanosine in asymptomatic HIV-infected children with plasma HIV RNA below 50,000 copies per milliliter.
    de Mendoza C; Ramos JT; Ciria L; Fortuny C; García FJ; de José MI; Asensi F; Soriano V
    HIV Clin Trials; 2002; 3(1):9-16. PubMed ID: 11819180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Anastassopoulou CG; Touloumi G; Katsoulidou A; Hatzitheodorou H; Pappa M; Paraskevis D; Lazanas M; Gargalianos P; Hatzakis A
    J Virol Methods; 2001 Jan; 91(1):67-74. PubMed ID: 11164487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of costs of strategies for measuring levels of human immunodeficiency virus type 1 RNA in plasma by using Amplicor and Ultra Direct assays.
    Raboud JM; Seminari E; Rae SL; Harrigan PR; Hogg RS; Conway B; Sherlock C; Schechter MT; O'Shaughnessy MV; Montaner JS
    J Clin Microbiol; 1998 Nov; 36(11):3369-71. PubMed ID: 9774597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of once and twice daily dosing of didanosine in combination with stavudine for the treatment of HIV-1 infection. AI 454-146 Team.
    Monno L; Cargnel A; Soranzo ML; Chirianni A; Ferraro T; Di Stefano M; Angarano G
    Antivir Ther; 1999; 4(4):195-202. PubMed ID: 10723498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma.
    Schuurman R; Descamps D; Weverling GJ; Kaye S; Tijnagel J; Williams I; van Leeuwen R; Tedder R; Boucher CA; Brun-Vezinet F; Loveday C
    J Clin Microbiol; 1996 Dec; 34(12):3016-22. PubMed ID: 8940441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative quantification of diverse serotypes of HIV-1 in plasma from a diverse population of patients.
    Clarke JR; Galpin S; Braganza R; Ashraf A; Russell R; Churchill DR; Weber JN; McClure MO
    J Med Virol; 2000 Dec; 62(4):445-9. PubMed ID: 11074472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
    Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
    Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.